All posts by imreal

A2LA Accredits North Coast Analytical Laboratories and North Coast Testing Laboratories to ISO/IEC 17025


News Image

“Our accreditation by A2LA is a testament to our ability to meet the most rigorous quality management standards in analytical testing of hemp products, and a vote of confidence in our team’s ability to perform at the highest levels.” – Nick Szabo, Laboratory Director, North Coast Analytical.

A2LA is pleased to announce the accreditation of both North Coast Analytical Laboratories and North Coast Testing Laboratories to ISO/IEC 17025:2017 for cannabis testing. Both of these laboratories are located in Streetsboro, Ohio and are A2LA’s first accredited cannabis testing laboratories in the state. North Coast Testing provides testing to service the medical marijuana industry and North Coast Analytical provides testing to service the hemp industry.

“We are extremely proud of the work of our entire team in rapidly developing and implementing a comprehensive quality management program that can give all participants in the Ohio Medical Marijuana Control Program confidence in the quality and safety of products tested in our laboratory,” said Carolyn Friedrich, Ph.D., Scientific Director at North Coast Testing.

“Our accreditation by A2LA is a testament to our ability to meet the most rigorous quality management standards in analytical testing of hemp products, and a vote of confidence in our team’s ability to perform at the highest levels,” said Nick Szabo, Laboratory Director at North Coast Analytical. “A2LA went above and beyond at every step, and we greatly appreciate their efforts.”

“We congratulate North Coast Analytical Laboratory and North Coast Testing Laboratory for being the first accredited cannabis testing laboratories in the state of Ohio”, said Chris Gunning, Accreditation Services General Manager at A2LA. Their commitment to excellence was evident in the facilities that they have constructed, the staff they have assembled, and the quality system they have implemented. This dedication to quality results will be an asset to customers in Ohio.”

Achieving ISO/IEC 17025 accreditation by A2LA is the pinnacle in third-party laboratory accreditation, as it confirms that laboratories have management, quality, and technical systems in place to ensure accurate and reliable analyses, as well as proper administrative processes to ensure that all aspects related to the sample, the analysis, and the reporting are standardized, measured, and monitored.

About A2LA

A2LA is a non-profit, non-governmental, third-party accreditation body, offering internationally-recognized accreditation services and training to testing and calibration laboratories, sampling organizations, inspection bodies, proficiency testing providers, reference material producers and product certifiers. For more information about A2LA, please visit http://www.A2LA.org.

About North Coast Testing Laboratories, LLC

North Coast Testing Laboratories, LLC is a full-service ISO 17025-accredited medical marijuana testing laboratory focused on providing precise analytical test results and guaranteed turnaround times. Made up of a team of industry-leading scientists possessing an in-depth knowledge of cannabis and cannabis infused products, North Coast Testing has combined cutting-edge technologies, principled laboratory practices and unparalleled customer service to bring the medical marijuana testing industry the most reliable analytical results possible.

About North Coast Analytical Laboratories, LLC

North Coast Analytical Laboratories, LLC is a full-service ISO 17025-accredited cannabis testing laboratory focused on providing precise analytical test results and guaranteed turnaround times. Made up of a team of industry-leading scientists possessing an in-depth knowledge of cannabis and cannabis infused products, North Coast Analytical has combined cutting-edge technologies, principled laboratory practices and unparalleled customer service to bring the hemp and CBD-products industry the most reliable analytical results possible.

Share article on social media or email:

World’s Greatest (Photoshop) Dad Shows What Kids Do When Nobody’s Looking


https://www.prweb.com/

It’s the secret lives of babies, and we’ve never seen them so clearly.

The last time the world saw Hannah Crowley, she was an infant perched above a lake, dangling from a banister, steering a car and making parents everywhere lose their collective minds.

Her father Stephen’s Photoshop skills made the images possible. Now he and Hannah are back, working on a new project to help kids facing real-life danger.

In 2017, Hannah was emerging from hospitalization and treatment for a rare immune disorder, which involved chemotherapy and a bone marrow transplant. Stephen took photos of her out and about for the first time, and edited her into mischievous scenes to entertain their family. He shared the photos on Reddit and soon after, Mashable, CBS News, BuzzFeed, The A.V. Club and other news outlets came calling.

Today, Hannah is a healthy preschooler and “the happiest kid in the world,” said Stephen. “She could not have made a more perfect recovery.”

Baby gear brand Summer remembered Stephen’s design wizardry and asked him to team up on a project. Summer wanted to showcase the high resolution of its new Baby Pixel Zoom HD video baby monitor by revealing what babies do when nobody’s looking.

Stephen created a series of new images that would make any parent drop their can of White Claw and run for the nursery.

“It’s the secret lives of babies, and we’ve never seen them so clearly,” said Summer VP Brand Marketing Jen Johnson.

“Caught in the Act” shows a baby scaling a shelf to reach a toy, escaping her crib and perched on the family dog – all from a baby monitor’s perspective.

For the shoot, Stephen enlisted the best photo assistant he knew: Hannah.

In the video trailer, Hannah, now 4 years old, can be seen assembling props, wearing her dad’s camera and helping him line up the perfect shot with a friend’s daughter.

Through the end of the year, Summer has committed to matching 10% of sales on the Baby Pixel Zoom HD monitor on summerinfant.com to Be The Match bone marrow registry, which Stephen credits with Hannah’s survival.

“There were only three potential matches for Hannah in the world, and Be The Match Registry is where we found them,” said Stephen.

“The funds raised through this partnership will help patients, just like Hannah, receive the care and treatment they need for a second chance at life,” said Be The Match Chief Advancement Officer Joy King.

“Hannah definitely inherited her dad’s sense of humor, and we love watching her on the other side of the camera for something that could help other kids survive a journey like hers,” said Johnson.

To see Stephen and Hannah’s latest creations and participate in the project, visit summerinfant.com/caughtintheact.

About Summer™

Summer is dedicated to making bath time, meal time, play time and every time in between special for parents and children. For more than three decades, Summer’s thoughtfully designed, pioneering infant and toddler care products have made family life easier, safer and more fun. For more, visit summerinfant.com.

About SUMR™ Brands

Based in Woonsocket, Rhode Island, SUMR Brands is driven by a commitment to people, product, and purpose. The Company is made up of a diverse group of experts with a passion to make family life better. For more, visit sumrbrands.com.

About Be The Match®

For people with life-threatening blood cancers — like leukemia and lymphoma — or other diseases, a cure exists. Be The Match connects patients with their donor match for a life-saving marrow or umbilical cord blood transplant. People can contribute to the cure as a member of the Be The Match Registry®, financial contributor or volunteer. Be The Match provides patients and their families one-on-one support, education, and guidance before, during and after transplant. Be The Match is operated by the National Marrow Donor Program® (NMDP), a nonprofit organization that matches patients with donors, educates health care professionals and conducts research through its research program, CIBMTR® (Center for International Blood and Marrow Transplant Research®), so more lives can be saved. To learn more about the cure, visit BeTheMatch.org or call 1 (800) MARROW-2.

Share article on social media or email:

Hospital Billing Practices are Under a Microscope and Providers are Responding to the Public and Political Scrutiny


https://www.prweb.com/

Healthcare providers are learning that aggressive patient collection tactics damage their brands and alienate healthcare consumers

With patients on the hook for so much more of the cost, a provider’s reputation matters. Suing patients to collect from them and other aggressive collection tactics have no place in a business-building strategy. – Kevin Fleming, CEO, Loyale Healthcare

In recent months, U.S. news media have been paying closer-than-usual attention to the ways hospitals bill and collect from patients. The issues range from surprise bills to overzealous collection methods that have gone so far as to seize paychecks and tax refunds – even claim homes. This scrutiny has fueled mounting public anger, prompting U.S. lawmakers to launch an investigation into provider billing practices. The focus of this anger has also expanded to include the private equity owners of some U.S. healthcare companies.

These forms of behavior turn the provider-patient relationship on its head – from care giver to financial adversary. Even more damaging, aggressive collection tactics frighten prospective patients. Concerned and uncertain about what they will owe and how they will pay for the care they need; many decide to skip care entirely. Research results vary on this topic, but the number of people who avoid or delay care because of concerns about their ability to afford it range from fifty percent to sixty-four percent.

There are two sides to this story. Healthcare providers are in a tough spot, too. They are expected to deliver exceptional clinical care and required to meet high regulatory standards. At the same time, they are struggling to collect from financially burdened patients with systems that were developed decades ago to collect from insurance companies. The solution to this problem, it seems, depends on providers’ willingness to abandon adversarial tactics and embrace a more personal, compassionate approach.

Healthcare in a Consumer-Driven Market: Brand Matters

You may have heard the expression, “there’s no such thing as bad publicity”, but ask any executive in an industry that relies on the good will of the buying public and they’ll tell you otherwise. Trusted companies like Disney, Apple, Nike and others spend untold millions in time and money to maintain, protect and grow brands that cultivate long-term consumer relationships. How these companies are perceived in the marketplace is fundamental to their continued success.

Healthcare now finds itself in a similar spot. When the insurance companies did most of the paying, a hospital’s brand was primarily clinical in nature and the financial experience didn’t matter that much. Patients chose the providers that were in their plan’s network, the provider delivered treatment and the payer paid. But now that patients are on the hook for so much more of the cost, they’re behaving differently. Suddenly, a provider’s reputation matters. In such an environment, suing patients to collect from them and other aggressive collection tactics have no place in a business building strategy.

Instead, more and more providers are developing consumer-centric, retail-like experiences. Recognizing that patient preference will be the principle driver of volume and revenue, they’re reimagining the patient experience from new, much larger perspectives. HCA Healthcare is one example. One of the largest and most successful healthcare brands in America, HCA is focused on constantly improving the patient’s financial journey.

Loyale Healthcare has partnered with over 12,000 healthcare facility customers representing in excess of $50 Billion in annual net patient revenue and forty million patient encounters. With a focus on delivering end-to-end functionality, our solution supports six key patient financial elements, all of which contribute to improved patient financial experiences and provider brand value:

1.    Price transparency – One of the biggest problems facing the healthcare industry’s transition into a consumer-first operating model is its pervasive inability to provide patients with reliable upfront estimates for care. In every other purchase decision we consumers make, price is one of the most important considerations. Until now, healthcare has been exempt, but those days are numbered. The government and powerful new competitors like Haven Healthcare, CVS Health and others will see to that.

2.    Payment planning – When a patient knows early what their care is likely to cost, and how much their out-of-pocket will be, they can plan for the expense. With Loyale’s Affordability Workbench™, patients have access to multiple payment options that include discounts for early or prompt payment; short-term, no interest payment schedules; or longer-term payment plans through a third-party lender. Serving themselves online, or working with hospital staff, patients can get the care they need while focusing on payments they can afford, not just worrying about what they’ll owe.

3.    Personalized digital & human communications – Patients are often slow to react to traditional hospital billing communications. Whether sent by mail, email or online over the hospital’s patient portal, form letters do nothing to engage patients or provide the clarity they need to understand and act on their financial obligations. Loyale’s personalized digital communication platform, on the other hand, automatically segments patient populations. By integrating with patient preferences, we then deliver the right messages at the right frequency over the right channel – email, text, chat or by initiating a human conversation.

4.    One Bed. One Bill – Ask most patients and they’ll tell you… they’re confused, frustrated and angry about their healthcare bills. “It was one stay in one bed for one thing. Why did I get eleven bills?” With the Loyale platform, Providers can now consolidate bills into one, comprehensive virtual “bill” presentation that patients can understand and act on. Loyale’s underlying technology takes care of making sure the payments get where they need to go.

5.    Seamless, holistic experiences – Healthcare has long separated patient experiences into two different categories; the clinical and the administrative/financial. But patients will tell you that they have just one care experience, and that experience includes every interaction the patient has with the provider, every time. That’s why Loyale integrates with the Provider’s clinical portal. Additionally, its provider-facing portal gives hospital staff and call centers the patient’s account view for easy problem solving.

6.    Provider facing tools to improve productivity and increase revenues – Beginning well before treatment, the Loyale patient financial engagement platform collects and aggregates data to qualify patients. Then the system automatically generates intelligent workflows that reduce staff work and improve the probability of patient payment. Additionally, the tool’s highly configurable reporting and dashboard functionality is now giving health systems the “best visibility into patient-pay revenue cycle they have ever had”. This invaluable business intelligence is making it possible for leadership to find and promote best practices and tackle underperforming practices.

By delivering patient-first financial experiences, healthcare providers across the country are finding that patients are eager to engage. This leads to dramatic increases in patient self-service, reduced costs for traditional paper billing and collections and higher patient-pay revenue. Best of all, it responds to patient expectations for transparency, clarity and inclusion. By partnering with them in the financial dimension of care, healthcare can now provide patients and their communities with healthcare financial experiences they can understand and control.

Kevin Fleming is the CEO of Loyale Healthcare

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale recently announced an Enterprise level strategic partnership with Parallon including deployment of its industry leading technology to all HCA hospitals and Physician Groups.

ASGCT Presents Career Development Awards to Six Members


ASGCT’s Career Development Awards support independent transformative pilot studies in gene and cell therapy conducted by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms.

The American Society of Gene and Cell Therapy (ASGCT) has selected six members to receive $50,000 Career Development Awards, a total distribution of $300,000. This group of awardees is ASGCT’s second class of Career Development Award recipients, a program in which ASGCT recognizes members who are transitioning toward independence in their careers.

ASGCT’s Career Development Awards support independent transformative pilot studies in gene and cell therapy conducted by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms. The Society is also interested in helping applicants generate preliminary data to use in larger proposals (NIH K awards, first-submission R-level funding, etc.). The recipients were chosen by a selection committee made up of industry leaders identified by the ASGCT Board of Directors.

ASGCT’s six awardees are a diverse group from varied and wide-ranging specialties:

Mohommadsharif Tabebordbar, Ph.D.—postdoctoral associate, Broad Institute of MIT and Harvard

Developing liver-detargeted and muscle-tropic AAV capsid variants across species

Geoffrey L. Rogers, Ph.D.—postdoctoral scholar, University of Southern California

Improved strategies for site-specific gene insertion using non-homologous end joining

Daniel L. Kiss, Ph.D.—assistant professor, Houston Methodist Research Institute

Construction of circular RNAs to block miRNA-driven oncogenic transformation

Kshitiz Singh, M.B.B.S., M.M.S.T., Ph.D.—research fellow, Children’s Hospital of Philadelphia

Development of non-viral mechanisms of targeting lung epithelial cells for prenatal gene editing in a large animal model

Christopher Nelson, Ph.D.—assistant professor, University of Arkansas

Characterizing and overcoming the host response to genome editing therapy

Kalpana Parvathaneni, MS, Ph.D.— postdoctoral researcher, Center for Cellular Immunotherapies, University of Pennsylvania

Engineered CAR-T Cells to Overcome Alloimmunity in Transplant Rejection

ASGCT is honored to have received such strong interest from its membership and congratulates this strongly-qualified group of awardees. The 2020 Career Development Awards program will begin accepting applications shortly after the 23nd ASGCT Annual Meeting, May 12-15, held at the Hynes Convention Center in Boston.

About ASGCT

The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

Share article on social media or email:

LaneTerralever Appoints Chris Johnson CEO as Beau Lane Moves into Executive Chairman Role


https://www.prweb.com/

LaneTerralever CEO and President Chris Johnson and Executive Chairman Beau Lane

“Chris and I have always operated as true partners, making this a natural evolution of the roles we are each already fulfilling in the business. Chris is a superb operator, visionary and strategic leader which are ideal skills for the CEO position.” – Beau Lane, LaneTerralever Executive Chairman

After twenty-five years as CEO at AdAge-honored, independent marketing agency, LaneTerralever, Beau Lane is passing his title to current President and partner, Chris Johnson. Moving forward Johnson will serve as President and CEO while Lane will continue to guide the company mission as newly appointed, Executive Chairman.

“Chris and I have always operated as true partners, making this a natural evolution of the roles we are each already fulfilling in the business. Chris is a superb operator, visionary and strategic leader which are ideal skills for the CEO position,” shared LaneTerralever Executive Chairman Beau Lane.    

Lane and Johnson originally met while their respective companies, Phoenix advertising agency, E. B. Lane, and Tempe digital marketing firm, Terralever, saw an opportunity to create an improved agency model to better serve the needs of the modern marketer. By unifying traditional advertising with digital capabilities, they could create a one-stop shop. From there, a mutual courtship begun with the two forming LaneTerralever in 2013. Today, their combined focus on client satisfaction and marketing innovation has solidified the company as one of the Southwest’s largest, award-winning, independent marketing agencies.

Lane comes from a family of marketers, with both his parents founding E. B. Lane & Associates in 1962. Lane officially joined the family agency in the mid 80’s after working in the publishing, broadcasting and advertising business in Colorado. In 1994, at 32 years old, he took over as CEO of E. B. Lane after acquiring the agency. In his time, he helped garner national and local recognition for award-winning work and secured numerous high-profile clients such as the Arizona Cardinals, Cox Communications, Paramount Pictures, the Arizona Lottery and Toyota.

Johnson’s experience started while working as a general manager of a publicly held professional services organization. In 2002 he recognized a need in the market for highly skilled technology competencies, creative and strategic counsel in one shop. From here Terralever was born – a firm that leveraged both technology and world-class digital design to solve real business problems. Johnson served as CEO and founder, collaborating with digital leaders like Microsoft and Facebook to lead clients like Red Bull and Time Warner Cable to success. In 2013 his team notably received a Bronze Stevie® Award in Media & Entertainment for their website IndyCar.com.

While serving as LaneTerralever’s President and CEO, Johnson will continue to grow the business in higher education, casinos and gaming, entertainment and attractions, real estate, multi-unit franchises and realtors, healthcare and additional industry expansion. He will also continue to drive innovation in the Valley by serving on the Arizona Technology Council board and serving as a strategic advisor to the SciTech Foundation.

“I’m excited to continue the evolution of LaneTerralever, leading our amazing collection of talented people into the future of marketing and driving innovative success for our clients,” shared Johnson.

Along with serving as LaneTerralever’s Executive Chairman, Lane will continue to serve as Vice Chair of the Phoenix Community Alliance, board member of the ASU Cronkite School of Journalism, board member of Grand Canyon University Colangelo School of Business, member of Greater Phoenix Leadership, member of the Marketing and Advertising Global Network, member of The Phoenix Business Journal Leadership of Trust, member of Fighter Country Partnership Foundation and as a member of YPO Gold.

“I’m looking forward to continuing to exercise my strengths in high-level client relationships, business development and community and industry relations. This, along with Chris’s strategic insight and competitive expertise, makes for a powerful combination — precisely what we planned for when we merged our firms six years ago.”

For more information, go to LaneTerralever.com.

About LaneTerralever

Recognized as one of the region’s largest independent marketing agencies, Phoenix-based LaneTerralever derives award-winning success from understanding their customers’ unique journey, building brand experiences that drive action, and developing marketing strategies for transformative growth – all while maintaining a client satisfaction Net Promoter Score of 81, compared to an industry average of 15.

LaneTerralever provides brand strategy, strategic planning, design, website development, user experience, content strategy, media strategy and buying, public relations, video production, acquisition and lead generation, social media and direct response advertising services for clients such as Golden Entertainment, Universal Technical Institute, The Joint Chiropractic, Lyft, Valley Toyota Dealers, Discount Tire, American Vision Partners, Arizona Cardinals, Phoenix Children’s Hospital and The Phoenix Zoo.

Share article on social media or email:

Worcester Polytechnic Institute Researcher Creating Safer, More Accurate Way to Detect Prostate Cancer


Haichong "Kai" Zhang

Haichong “Kai” Zhang is developing an MRI-guided robotics system to detect and monitor prostate cancer.

A biomedical engineer at Worcester Polytechnic Institute (WPI) is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.

Haichong (Kai) Zhang, assistant professor in biomedical engineering and robotics engineering, received a five-year $1,869,423 Director’s Early Independence Award from the National Institutes of Health (NIH) for his ongoing work to create a robotic system that will detect and analyze three different indicators of prostate cancer: a 3D image of any mass; high levels of a protein produced by cancer cells; and tissue with low-oxygen levels caused by cancer growth.

By simultaneously focusing on these different but complementary signs of prostate cancer, Zhang expects his system will be more accurate than current tests like ultrasounds and biopsies unguided by MRIs. His work also may eliminate the need for radioactive contrast dye, which is used in traditional scans and poses other health risks.

“One fifth of men will be diagnosed to have prostate cancer in their lifetime and the recurrence of it is very high,” said Zhang, who is the PI on the research project, “Multiparametric Photoacoustic Imaging-Based Identification of Aggressive Prostate Cancer” (DP5 OD028162).

“Right now,” he said, “the best methods for detecting prostate cancer early are not nearly as accurate as we need them to be, and they are not risk-free. My goal is to create a minimally invasive, easily accessible, and cost-effective way to better detect this cancer.”

According to 2016 cancer data from the NIH, prostate cancer was the most commonly diagnosed non-cutaneous cancer and nearly 200,000 new cases were diagnosed in the U.S. that year. Diagnosis of prostate cancer generally involves a blood test to check for prostate-specific antigens (PSA) that may indicate cancer, a manual rectal examination, biopsies, and ultrasounds. Biopsy samples taken randomly often lead to the underestimation of a high-risk prostate cancer, false negative diagnoses, and the need for repeat biopsies. The NIH reported that the grade or stage of prostate cancer was only accurately determined in 37% of biopsied cases.

Zhang and Gregory Fischer, professor of robotics engineering and a widely known pioneer in the emerging field of MRI-guided robotic surgery, will create a surgical imaging robot that works within an MRI machine to insert an imaging probe into the patient’s rectum, adjacent to the prostate. Once an image is captured, the probe will be robotically manipulated so it can capture other images from slightly different angles, ultimately compiling a 3D image of the prostate and any tumor that is present. This technology will show the tumor in earlier stages than an ultrasound image, which generally shows the structure of the prostate but not a tumor’s location, and often fails to detect early stage tumors. The robotic system also is being designed to conduct guided-needle biopsies. By using the photoacoustic system, the robotic arm can pinpoint the tumor and specifically target it.

Zhang’s robotic device will use photoacoustic imaging, which is the combination of optical imaging and ultrasound, pulsing light into tissue and receiving acoustic waves in return. The acoustic signal provides information about the health of the tissue, which a traditional ultrasound does not. Different kinds of tissue emit different kinds of acoustic waves so the system will be able to differentiate between healthy, well-oxygenated tissue and tissue that is hypoxic, or depleted of oxygen. Cancer cells reduce the transportation of oxygen and nutrients in surrounding blood vessels.

“Three-D images, PSMA detection and hypoxia detection are all complimentary,” said Zhang. “They all give us different clues, different approaches to detecting cancer at a much higher sensitivity. That means we should be able to detect prostate cancer earlier when it’s much more treatable.”

Fischer said he is excited to work with Zhang to create the next-generation of his MRI-guided robot for prostate cancer detection and treatment. “With Zhang’s technology, we’ll have a greater ability to identify a mass and to directly target it with a biopsy needle. That’s key.”

Zhang also is working with researchers at Johns Hopkins University to develop a non-radioactive contrast agent that can be used during the photoacoustic imaging to target PSMA, a specific protein expressed in prostate cancer that may indicate the presence of an aggressive form of the disease. This may eliminate the need for current contrast agents, which are radioactive and can pose additional health risks.

The NIH Director’s Early Independence Award, established in 2010, is part of the organization’s High-Risk, High-Reward Research Program, which supports what the NIH describes as “exceptionally creative scientists pursuing highly innovative research with the potential for broad impact.” The award provides an opportunity for junior scientists who have recently received their doctoral degrees or completed medical residency to skip traditional post-doctoral training and move immediately into independent research positions. Thirteen such awards will be made for 2019.

Zhang earned his PhD in computer science at Johns Hopkins. While there, he received a nearly $200,000 grant from the Department of Defense and the Congressionally Directed Medical Research Programs to work on imaging research related to his current project.

About Worcester Polytechnic Institute

WPI, a global leader in project-based learning, is a distinctive, top-tier technological university founded in 1865 on the principle that students learn most effectively by applying the theory learned in the classroom to the practice of solving real-world problems. Recognized by the National Academy of Engineering with the 2016 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education, WPI’s pioneering project-based curriculum engages undergraduates in solving important scientific, technological, and societal problems throughout their education and at more than 50 project centers around the world. WPI offers more than 50 bachelor’s, master’s, and doctoral degree programs across 14 academic departments in science, engineering, technology, business, the social sciences, and the humanities and arts. Its faculty and students pursue groundbreaking research to meet ongoing challenges in health and biotechnology; robotics and the internet of things; advanced materials and manufacturing; cyber, data, and security systems; learning science; and more. http://www.wpi.edu

Media contact:

Alison Duffy, Director of Strategic Communications

Worcester Polytechnic Institute

Worcester, Massachusetts

508-831-6656, amduffy@wpi.edu

HMP Expands Partnership with the International Certification & Reciprocity Consortium


News Image

In the midst of an unprecedented addiction crisis, this partnership provides thousands of IC&RC-credentialed professionals access to critical, evidence-based education presented by the field’s leading experts.

HMP, a leading healthcare event and education company, today announced an expanded partnership with the International Certification & Reciprocity Consortium (IC&RC), the leader in the credentialing of prevention, substance use treatment, and recovery professionals. As part of the arrangement, the National Conference on Addiction Disorders (NCAD) East and West, part of HMP’s Psychiatry & Behavioral Health Learning Network, are official conferences of IC&RC. The two organizations will work jointly on educational and marketing initiatives around the two meetings.

Organized in 1981, IC&RC is the largest credentialing organization in the world and represents more than 50,000 professionals in the U.S. and globally. IC&RC promotes public protection by offering internationally recognized credentials and examinations to professionals.

For more than ten years, the NCAD brand has focused on delivering exceptional face-to-face education to address addiction disorders. In 2019, the meeting expanded into East and West offerings. Through comprehensive clinical agendas, the meetings allow attendees to hear new research and share cross-discipline insight on forward-thinking topics such as medication-assisted treatment, benzodiazepine use, and advances in treatment technologies. Nearly 1,000 professionals participated in NCAD East in Baltimore, Maryland, in August, and 400 are expected to participate in the inaugural NCAD West, taking place October 24–26 in Denver, Colorado.

“We are honored to be strengthening our collaboration with IC&RC,” said Doug Edwards, Director, HMP Psychiatry & Behavioral Health Learning Network. “In the midst of an unprecedented addiction crisis, this partnership provides thousands of IC&RC-credentialed professionals access to critical, evidence-based education presented by the field’s leading experts in order to continue to advance the profession and quality care for those challenged by addiction.”

“The IC&RC looks forward to this enhanced strategic partnership with HMP,” said Crystal Smalldon, RSSW, CCAC, CIAC, IC&RC President and Executive Director. “Together, IC&RC and HMP are committed to advancing the profession. HMP produces the leading national conferences in this field, and this agreement provides a unique opportunity to provide our community of professionals the highest quality education to continually improve and refine patient care and recovery services. This represents real impact.”

To learn more about NCAD East and West, visit theaddictionconference.com.

For media inquiries, contact Kelly McCurdy at pr@hmpglobal.com.

About HMP

HMP is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; Rx Drug Abuse & Heroin Summit, the largest annual gathering on the opioid crisis; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

About the International Certification & Reciprocity Consortium (IC&RC)

IC&RC promotes public protection by setting standards and developing examinations for the credentialing and licensing of prevention, substance use treatment, and recovery professionals. Organized in 1981, IC&RC has 73 member certification and licensing boards in 48 U.S. states and territories, four Native American regions, all branches of the U.S. military, and 11 international regions. Representing more than 50,000 professionals, IC&RC is the global leader in the credentialing of prevention, substance use treatment, and recovery professionals. To learn more about IC&RC, visit internationalcredentialing.org.

Share article on social media or email:

Virtue Technologies Announces Investment by Claritas Capital


News Image

“We are excited and encouraged in the market’s response to Virtue Technologies,” says Gibran Ameer, “moreover, we are very pleased in the confidence that Claritas Capital has placed in us.”

Virtue Technologies, a leading provider of post-acute healthcare technology solutions, announced today that Claritas Capital, a Nashville-based private equity firm, has invested in the company. Created out of a joint venture between TwelveStone Health Partners and VirtueRN, the new company addresses the fragmented market that exists among organizations who communicate orders to service providers and the patients who need them in post-acute care environments. The solutions streamline workflow processes and increase the level of communication that occurs across the continuum of post-acute care.

“The delivery of post-acute care can often be quite challenging,” says Gibran Ameer, Chief Executive Officer of Virtue Technologies. “Technology is a means to un-complicate and simplify business processes – our solutions do just that. This results in a positive impact to operational efficiencies, costs, revenue cycle and ultimately a better patient experience.”

“Virtue Technologies is unique as they have successfully developed innovative technology solutions based on the founders’ deep understanding of the complexities associated with providing care and serving patients in the post-acute care market,” said Theresa Sexton, Partner, Claritas Capital. “We are excited to support the Virtue Technologies team as they provide solutions which promote service excellence, increase productivity, and fills the gaps in an otherwise fragmented marketplace.”

“We are excited and encouraged in the market’s response to Virtue Technologies,” says Gibran Ameer, “moreover, we are very pleased in the confidence that Claritas Capital has placed in us.”

About Virtue Technologies

Virtue Technologies is a provider of cloud-based software committed to solving the challenges of the highly fragmented pharmacy market. The solutions strive to drive out cost and improve a pharmacy’s revenue cycle by improving staff efficiency, removing waste, increasing patient satisfaction, and providing unparalleled visibility to pharmacy operations. In an environment of shrinking reimbursements, growing audit risk, and persistent demand from patients and caregivers, Virtue Technologies provides the solutions the market demands.

About Claritas Capital

Nashville-based Claritas Capital has been making health care investments since its founding in 2002. The Principals’ experience covers three decades of investing in the health care industry. Claritas Capital provides flexible capital solutions to health care, technology, and business services companies, and real estate projects. The firm has made equity investments in over 50 companies that have collectively raised over $6 billion of financing.

Jason Jacobs, COO

Virtue Technologies

jason.jacobs@virtuescript.com

(803) 932-6450

Kali Huff, Investor Relations

Claritas Capital

khuff@claritascapital.com

(615) 690-7183

Share article on social media or email:

KnowBe4 Finds Email Subject Lines Focused on Security-Minded End Users are Effective


https://www.prweb.com/

KnowBe4 Q3 2019 Phishing Report Infographic

As cybersecurity threats persist, more and more end users are becoming security minded. The bad guys are always looking for clever ways to trick end users, so they need to remain vigilant. -Stu Sjouwerman, CEO, KnowBe4

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, revealed the results of its Q3 2019 top-clicked phishing report.

The results found that simulated phishing tests with an urgent message to check a password immediately were most effective, with 43% of users falling for it. Social media messages are another area of concern when it comes to phishing. Within the same report, KnowBe4’s top-clicked social media email subjects reveal that LinkedIn messages are the most popular at 48%, followed by Facebook at 37%.

“As cybersecurity threats persist, more and more end users are becoming security minded,” said Stu Sjouwerman, CEO, KnowBe4. “They have a vested interest in protecting their online lives, so a message that sounds urgent related to their password can entice someone to click. The bad guys are always looking for clever ways to trick end users, so they need to remain vigilant.”

Rounding out its quarterly reviews, in Q3 2019, KnowBe4 examined tens of thousands of email subject lines from simulated phishing tests. The organization also examined ‘in-the-wild’ email subject lines that show actual emails users received and reported to their IT departments as suspicious. The results are below.

The Top 10 Most-Clicked General Email Subject Lines Globally for Q3 2019 include:

  • Password Check Required Immediately
  • A Delivery Attempt was made
  • De-activation of [[email]] in Process
  • New food trucks coming to [[company_name]]
  • Updated Employee Benefits
  • Revised Vacation & Sick Time Policy
  • You Have A New Voicemail
  • New Organizational Changes
  • Change of Password Required Immediately
  • Staff Review 2018


*Capitalization and spelling are as they were in the phishing test subject line.

**Email subject lines are a combination of both simulated phishing templates created by KnowBe4 for clients, and custom tests designed by KnowBe4 customers.

When investigating ‘in-the-wild’ email subject lines, KnowBe4 found the most common throughout Q3 2019 included:

  • Skype: New Unread Voicemail Message
  • Transaction Refund
  • [[NAME]] shared a document with you
  • Microsoft Teams: Please authenticate your account
  • Bonus payments for selected employees
  • Cisco Webex: Your account is blocked
  • Amazon: Billing Address Mismatch
  • USPS: High Priority Package: Track it now!
  • Verizon: Security Update
  • Adobe Cloud: Shared a file with you on Adobe Cloud


*Capitalization and spelling are as they were in the phishing test subject line.

**In-the-wild email subject lines represent actual emails users received and reported to their IT departments as suspicious. They are not simulated phishing test emails.

For more information on KnowBe4, visit http://www.knowbe4.com.

About KnowBe4

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, is used by more than 28,000 organizations around the globe. Founded by IT and data security specialist Stu Sjouwerman, KnowBe4 helps organizations address the human element of security by raising awareness about ransomware, CEO fraud and other social engineering tactics through a new-school approach to awareness training on security. Kevin Mitnick, an internationally recognized cybersecurity specialist and KnowBe4’s Chief Hacking Officer, helped design the KnowBe4 training based on his well-documented social engineering tactics. Tens of thousands of organizations rely on KnowBe4 to mobilize their end users as the last line of defense.

Number 161 on the 2019 Inc. 500 list, #34 on 2018 Deloitte’s Technology Fast 500 and #2 in Cybersecurity Ventures Cybersecurity 500. KnowBe4 is headquartered in Tampa Bay, Florida with European offices in England, the Netherlands, Germany and offices in Brazil, Australia, Japan, South Africa and Singapore.

Share article on social media or email:

IRONSCALES Wins Cyber Defense Magazine’s Global Award for Best Anti-Phishing Security Solution


News Image

We are honored that Cyber Defense Magazine recognizes our efforts to pioneer the type of next generation anti-phishing technology essential to not just reduce risk but also to make the lives of security pros more manageable.

IRONSCALES, the world’s first automated phishing prevention, detection and response platform, today announced that it has won Cyber Defense Global Award’s Next Gen Award for Best Anti-Phishing Security Solution from Cyber Defense Magazine, the industry’s leading electronic information security magazine. Leading the charge in email security, IRONSCALES was chosen out of 3,000 cybersecurity companies as a globally recognized information security leader by a panel of independent information security experts after months of review.

“With cybercrime heading into the tens of billions of records stolen and potentially trillions of dollars in damages, we are proud to recognize IRONSCALES as an award-winning innovator that offers a new approach to defeat these criminals,” said Pierlugi Paganini, editor-in-chief, Cyber Defense Magazine.

This award continues a legacy of recognition from Cyber Defense. Last year, the publication named IRONSCALES’s autonomous SOC, Themis, the Most Innovative Anti-Phishing Solution.

“As the email threat landscape becomes more sophisticated, our mission is to keep SOC and IT security teams two steps ahead of attackers while reducing the current burdens imposed on them by manual incident investigation and response,” said Eyal Benishti, CEO and founder of IRONSCALES. “We are honored that Cyber Defense Magazine recognizes our efforts to pioneer the type of next generation anti-phishing technology essential to reduce risk while making the lives of security pros more manageable and less stressful.”

To help solve the phishing epidemic, IRONSCALES helps where e-mail security hurts the most, in the inbox with post-message delivery, detection and remediation. Through a self-learning platform that provides for fast, easy and seamless collaboration, IRONSCALES puts its customers on offense, empowering them to defend against sophisticated email attack techniques automatically in a proactive and predictive manner. Using a decentralized approach to threat intelligence sharing, IRONSCALES makes anti-phishing effortless and seamless for both security professionals and end users. Additionally, IRONSCALES is the only email security provider to offer mobile applications for iOS and Android, enabling security analysts to access the platform’s incident response center while on the go, providing unprecedented access to make time-sensitive decisions on phishing mitigation and resolve incidents immediately with one click.

Earlier this year, the company also won Gold for automation in email security at the 15th Annual 2019 Info Security Product Guide’s Global Excellence Awards® and was named the Enterprise Email Security Solution of the Year by the Cybersecurity Breakthrough Awards in 2018.

For more information about IRONSCALES, visit http://www.ironscales.com and follow @ironscales on Twitter and LinkedIn.

About IRONSCALES

IRONSCALES is the leader in anti-email phishing technologies. Using a multi-layered and automated approach to prevent, detect and respond to today’s sophisticated email phishing attacks, IRONSCALES expedites the time from phishing attack discovery to enterprise-wide remediation from months to seconds, by significantly reducing the workload on incident responders. With headquarters in Tel Aviv and Atlanta, IRONSCALES was founded by a team of security researchers, IT and penetration testing experts, as well as specialists in the field of effective interactive training, in response to the phishing epidemic that today costs companies millions of dollars annually. It was incubated at the 8200 EISP, the top program for cyber security ventures, founded by alumni of the Israel Defense Forces’ elite Intelligence Technology unit.

About Cyber Defense Global Awards

This is Cyber Defense Magazine’s seventh year of honoring InfoSec innovators from around the globe. Our submission requirements are for any startup, early stage, later stage or public companies in the INFORMATION SECURITY (INFOSEC) space who believe they have a unique and compelling value proposition for their product or service. In this program, we are particularly interested in highlighting cybersecurity companies who have a presence outside of the USA and/or a more global focus. Learn more at http://www.cyberdefenseawards.com.

About Cyber Defense Magazine

With over 2 Million annual readers and growing, and over 8,000 pages of searchable online infosec content, Cyber Defense Magazine is the premier source of IT Security information. We are managed and published by and for ethical, honest, passionate information security professionals. Our mission is to share cutting-edge knowledge, real-world stories and awards on the best ideas, products and services in the information technology industry. We deliver electronic magazines every month online for free, and limited special editions exclusively for the RSA Conference USA, Black Hat USA and IPEXPO Europe. CDM is a proud member of the Cyber Defense Media Group. Learn more about us at http://www.cyberdefensemagazine.com and visit http://www.cyberdefensetv.com and http://www.cyberdefenseradio.com to see and hear some of the most informative interviews of many of these winning company executives.

Share article on social media or email: